Noveris Health Sciences Inc. is trading 8.5% lower at $2.70 as shares pull back from a recent multi-day rally amid a weaker broader market tape.
- The stock had previously climbed from $2.07 on May 29 to a high of $2.95 on June 8 before today's retracement.
- There are no fresh company-specific headlines or regulatory filings as of June 9, 2026, to account for the downward move.
- The decline appears to be a technical correction and profit-taking in a highly volatile name following its significant recent gains.